Retrophin Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
RETROPHIN INC (RTRX)
Last retrophin inc earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.retrophin.com/investor-relations
Company Research
Source: GlobeNewswire
SAN DIEGO, July 30, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the appointment of Noah L. Rosenberg, M.D., as chief medical officer, where he will oversee the clinical development of Retrophin’s product pipeline. Dr. Rosenberg brings to Retrophin more than 20 years of clinical and therapeutic development experience, including advancing several mid- and late-stage programs across therapeutic areas through to commercialization. “Noah’s expertise and career-long focus on therapeutic innovation and patient quality of care strengthens our leadership team and aligns seamlessly with our mission of identifying, developing and delivering life-changing therapies to people living with rare diseases,” said Stephen Aselage, chief executive officer of Retrophin. “We look forward to Noah’s contributions during this important time as we advance two pivotal Phase 3 programs in the clinic and multiple additional studies planned to begin later this year.” Dr. Rosenberg j
Show less
Read more
Impact Snapshot
Event Time:
RTRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RTRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RTRX alerts
High impacting RETROPHIN INC news events
Weekly update
A roundup of the hottest topics